numares Appoints Dr. Gregory Heath As New Member of the Supervisory Board and Submits an Additional Test to the FDA
Leading NMR diagnostics company numares AG appoints Dr. Gregory Heath as new member of the Supervisory Board. Dr. Heath has a long career in the diagnostics and life sciences industry, including long-term experience in the development and launching of in vitro diagnostics (IVDs). He will assist numares in the commercialization of multi-marker-based diagnostic tests running on the company’s proprietary, AI-driven IVD platform, the AXINON® System, for which the company applied for two 510(k) clearances this year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211215005040/en/
Dr. Gregory F. Heath, Member of the numares Supervisory Board (Photo: Business Wire)
“We are delighted to welcome Greg to the board,” said Dr. Volker Pfahlert, Chief Executive Officer of numares. “As we continue our focus on expansion in the United States, his depth of knowledge and substantial experience in the US diagnostics industry will help drive our diagnostic strategy and be invaluable to numares as it launches IVD products."
With his appointment, Dr. Heath joins the numares Supervisory Board as the second, independent US expert after Ms. Kathy Bates of Mayo Clinic Laboratories, who has been supporting the Supervisory Board as first US advisor since her election in 2019.
He brings with him more than 30 years of diagnostics experience. As a former General Manager of Diagnostics at Illumina Inc., Dr. Heath was responsible for building and managing the molecular Diagnostics Business Unit, as well as for the establishment of a CLIA lab and acquisition of service labs. Prior to this, he was SVP, Molecular Business at Roche Diagnostics, and held numerous roles in strategy, marketing, and business development during his career. He currently serves on the Scientific Advisory Board of Everlywell and is a strategic and scientific advisor to the diagnostics and life sciences industry.
Winton Gibbons, President of numares GROUP in the US and co-CEO of numares AG adds "Greg is a great addition to our Supervisory Board. His extensive experience in the diagnostics industry will help numares to commercialize its pipeline of new tests in the US. These include AXINON® GFR(NMR), a novel multi-marker kidney function test, recently submitted for FDA clearance."
Earlier this year, numares also announced its FDA 510(k) application for the AXINON® LDL-P test on the AXINON® System, an IVD platform based on Nuclear Magnetic Spectroscopy (NMR), combined with the company’s proprietary Magnetic Group Signaling (MGS®). MGS®enables simultaneous, highly standardized analysis of metabolites in human samples like blood and urine. The platform is used to develop and deploy novel diagnostic tests in clinical laboratories, applying the “numares model,” that identifies a set of metabolites, so-called "biomarker constellations,” via machine learning algorithms. This provides diagnostics solutions for the prevention and treatment of disease, including conditions in the kidney, heart, and liver, as well as cancer.
At the numares shareholders’ meeting in December 2021, Dr. Heath was elected as member of the supervisory board effective January 1st, 2022.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
For further information please contact:
Tel.: +49 941 280 949-14
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Dr. Philip Krause to Provide Strategic Advice to Adjuvance25.1.2022 15:35:00 CET | Press release
Adjuvance Technologies Inc., a privately-held clinical-stage biopharmaceutical company developing next generation saponin adjuvants and vaccines for infectious disease and immuno-oncology, today announced that Philip Krause, MD, will take on a strategic consulting role with the organization as it advances its vaccine development portfolio. Dr. Krause recently served as the Deputy Director, Office of Vaccines Research and Review of the US Food and Drug Administration (FDA) Center for Biologics Evaluation and Research. “The deep scientific, regulatory and vaccine development experience that Phil brings to Adjuvance will be instrumental in efficiently developing our shingles vaccine candidate and our pipeline anchored on the next-generation saponin adjuvant TQL-1055,” noted Dr. Tyler Martin, Adjuvance CEO, President and Chairman. “I am thrilled to enhance the company’s expertise with such a well-respected scientist.” Dr. Krause previously had a 30-year career in the FDA where he made majo
Andersen Global Adds Member Firms in Croatia25.1.2022 15:30:00 CET | Press release
Andersen Global continues to cultivate a strong European presence as Croatian tax and advisory firm Andersen BD d.o.o. (formerly BD Savjetovanje d.o.o.) becomes the organization’s newest member firm to adopt the Andersen brand. Andersen Global also welcomes member firm KALLAY & PARTNERS, a Zagreb-based law firm and collaborating firm since 2019. Together, the member firms will provide complementary tax and legal solutions, demonstrating the unified and seamless approach of the global organization. “As tax and legal legislation globally becomes more complex, we aim to continue providing best-in-class service and help our clients navigate the various aspects of their business operations,” said Branka Topolovec new Managing Partner of Andersen in Croatia. “The adoption of the Andersen brand is a milestone for our firm’s growth and development and gives us a competitive advantage in the market by allowing us to provide our clients with a full suite of capabilities in Croatia as well as glo
UVD Robots Joins Ecolab’s Global Infection Prevention Offerings to Fight Hospital Acquired Infections25.1.2022 15:02:00 CET | Press release
As new coronavirus variants spread, the growth in demand for infection prevention solutions using UV-C light is projected to reach $18.94 billion by 2030, witnessing an annual growth rate of 59.7% from 2021 to 2030. Further fueling the demand is the rise in hospital acquired infections (HAIs) globally causing more fatalities due to the increase in antibiotic resistance from even simple infections. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220125005148/en/ Disinfecting hospitals with UV-C lights is not a new concept, however, existing solutions including UV ceiling lights, stationary cleaning robots, and air purifiers may not reach shadowed or remote areas as well as the mobile platform offered by the autonomous UVD Robots. (Photo: Business Wire) Autonomous UV-C disinfection robots have emerged as a solution to supplement standard cleaning and disinfection practices to address HAIs and heightened hygiene requirements due
Alvaria Adds Real Time Intelligent AI Capability to Optimize Enterprise Contact Center Employees25.1.2022 15:00:00 CET | Press release
Alvaria, the world leader in enterprise-scale customer experience and workforce engagement management, announced the introduction of Alvaria Real Time Optimizer, a new cloud application of the Alvaria Workforce Engagement Management Suite that enhances the contact center agent experience. By functioning as a real-time virtual agent assistant, Alvaria Real Time Optimizer call center application completes activities, which positively impact key performance metrics, such as: Automatically monitors agent idle time and delivers training, coaching and off-phone tasks when service levels can best accommodate. – Streamlines communications Boost agent morale with automated delivery of surprise breaks, wellness breaks etc. – Increase agent satisfaction and engagement Automatically find the right time to connect agents with supervisors to ensure individual coaching is completed. – Protecting Service Level Consistently prompts agents with a helping hand when they go beyond thresholds for talk, hol
CSC Research Finds Third Parties Continue to Lay Groundwork for Malicious Activity Among Thousands of COVID-Related Domains25.1.2022 15:00:00 CET | Press release
CSC, a world leader in business, legal, tax, and domain security, today announced key findings from its new report, which found that nearly 500,000 web domains were registered since January 2020 containing key COVID-related terms. Many of these web domains can pose threats to brands and consumers due to their registration patterns and behaviors. This research is part of CSC’s latest report, “Two Year Analysis: The Impact of COVID-19 on Internet Security and Safety." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220125005112/en/ (Graphic: Business Wire) The report’s findings are gathered using CSC’s newly launched DomainSecSM platform, which makes the connections between newly registered, dropped, and existing domain names, online brands, and fraud (phishing). DomainSec is the first of its kind to deliver a holistic approach for securing and defending brands’ domain portfolio ecosystems. It uses proprietary technology combin
Bird Scales European Operations with Recent Permit Wins in France, Italy and the Netherlands25.1.2022 15:00:00 CET | Press release
Bird Global, Inc. (NYSE:BRDS), a leader in environmentally friendly electric transportation, today announced expansion of its micro-electric vehicle sharing service in the Dutch city of Amersfoort. The launch marks the debut of the company’s shared e-assist bikes in the Netherlands and builds on Bird’s recent e-assist bike permit awards and launches in Bordeaux, France and Rome, Italy. As demand for micro-electric vehicles continues throughout Europe, Bird is scaling the availability of its bike share service which complements its original e-scooter sharing offering. Following the launch in the Netherlands, the company plans to apply its operations permit to deliver a bike sharing service in Sesto Fiorentino, a town in the metropolitan area of Florence, Italy. The impending launch in Italy’s eighth-largest city will further Bird’s position as a leading micromobility provider in the country. Bird is now operational in over 350 cities globally including in more than 150 cities throughout
Merkle Unveils 2022 Imperatives to Address Customer Experience in a New Age25.1.2022 15:00:00 CET | Press release
Merkle (www.merkleinc.com), a leading technology-enabled, data-driven customer experience management (CXM) company, has unveiled its 2022 Customer Experience Imperatives. The executive guide is designed to help brands identify the key strategic considerations that will shape the year ahead and provide business leaders with actionable insights to create competitive advantage through marketing. This year, the Imperatives explore three themes, including data, measurement, and commerce’s impact on loyalty, and discuss how brands can approach each of these to stay ahead of the curve within their industries. “At Merkle, we are dedicated to helping brand leaders understand the role customer experience plays in driving their business forward. In the coming year, establishing deeper and more rewarding relationships with its customers will be a necessity for any business to achieve its goals,” said Michael Komasinski, global chief executive officer at Merkle/CXM. “The 2022 Customer Experience Im
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom